Repetitive transcranial magnetic stimulation (rTMS) for schizophrenia patients treated with clozapine
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00023752%3A_____%2F21%3A43920198" target="_blank" >RIV/00023752:_____/21:43920198 - isvavai.cz</a>
Alternative codes found
RIV/00216208:11120/21:43920030
Result on the web
<a href="https://www.tandfonline.com/doi/full/10.1080/15622975.2020.1733080" target="_blank" >https://www.tandfonline.com/doi/full/10.1080/15622975.2020.1733080</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1080/15622975.2020.1733080" target="_blank" >10.1080/15622975.2020.1733080</a>
Alternative languages
Result language
angličtina
Original language name
Repetitive transcranial magnetic stimulation (rTMS) for schizophrenia patients treated with clozapine
Original language description
Objectives: Biological strategies to improve treatment efficacy in clozapine-treated patients are urgently needed. Repetitive transcranial magnetic stimulation (rTMS) merits consideration as intervention for patients with persistent auditory hallucinations (AH) or negative symptoms (NS) not responding sufficiently to clozapine treatment. Methods: Data from 10 international RCTs of rTMS for patients being treated with clozapine were pooled. Two levels of symptomatic response were defined: improvement of ≥20% and ≥50% on study-specific primary endpoint scales. Changes in the positive and negative syndrome scale (PANSS) from baseline to endpoint assessment were also analysed. Results: Analyses of 131 patients did not reveal a significant difference for ≥20% and ≥50% response thresholds for improvement of AH, negative or total symptoms between active and sham rTMS groups. The number needed to treat (NNT) for an improvement in persistent AH was nine following active rTMS. PANSS scores did not improve significantly from baseline to endpoint between active and sham groups in studies investigating NS and AH. Conclusions: rTMS as a treatment for persistent symptoms in clozapine-treated patients did not show a beneficial effect of active compared to sham treatment. For AH, the size of the NNTs indicates a possible beneficial effect of rTMS.
Czech name
—
Czech description
—
Classification
Type
J<sub>imp</sub> - Article in a specialist periodical, which is included in the Web of Science database
CEP classification
—
OECD FORD branch
30215 - Psychiatry
Result continuities
Project
—
Continuities
V - Vyzkumna aktivita podporovana z jinych verejnych zdroju
Others
Publication year
2021
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Name of the periodical
World Journal of Biological Psychiatry
ISSN
1562-2975
e-ISSN
—
Volume of the periodical
22
Issue of the periodical within the volume
1
Country of publishing house
GB - UNITED KINGDOM
Number of pages
13
Pages from-to
14-26
UT code for WoS article
000519640300001
EID of the result in the Scopus database
2-s2.0-85081726819